Register entry

ROVI Pharma Industrial Services S.A.

Data as of · How to read this entry

Registered sites
4
Active NDC listings
16
Labeller names
2
Live patents
0
Countries
1
Base
Spain
Authorisation

Registered operations

Analytical testing3Labelling2Finished drug manufacture4Packaging3sterilize1
Sites

Registered establishments

4
EstablishmentAddressRegistered forFEI / DUNS
Rovi Pharma Industrial Services SACalle Via Complutense, 140, Alcala de Henares, 28805, Spain (ESP)Analytical testing, Labelling, Finished drug manufacture, Packaging3002989591462117953
Alloga Log�stica Espa�a S.L.Registrant: ROVI PHARMA INDUSTRIAL SERVICES S.A.POLIGONO INDUSTRIAL EL RABANAL, PAR P 71, FASE II 4, Illescas, Toledo 45200, Spain (ESP)Finished drug manufacture3027545805862911260
ROVI Pharma Industrial Services S.A.Juli�n Camarillo, 35, Madrid, 28037, Spain (ESP)Analytical testing, Labelling, Finished drug manufacture, Packaging, sterilize3007512884463584525
ROVI PHARMA INDUSTRIAL SERVICES S.A.Paseo de Europa, 50, San Sebasti�n de los Reyes, 28703, Spain (ESP)Analytical testing, Finished drug manufacture, Packaging3016688535469527153
Catalogue

Drug listings by form and route

16

16 active NDC listings: 6 bulk ingredient, 6 vaccine, 4 drug for further processing. By marketing category: DRUG FOR FURTHER PROCESSING 10, BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING 6.

Dosage formNDCs
injection6
injection, suspension4
solution2
suspension2
tablet2
RouteNDCs
Labeller name on the listingNDCs
rovi pharma industrial services s.a.12
rovi pharma industrial services sa4
Catalogue

Marketed products

16
BrandGeneric nameForm / routeNDC
-CX-038839 OMICRON (XBB.1.5)injection, suspension50024-100DRUG FOR FURTHER PROCESSING
-CX-038839 OMICRON (XBB.1.5)injection, suspension68263-001DRUG FOR FURTHER PROCESSING
-Moderna COVID-19 Vaccineinjection, suspension50024-300DRUG FOR FURTHER PROCESSING
-Moderna COVID-19 Vaccineinjection, suspension68263-012DRUG FOR FURTHER PROCESSING
-Respiratory Syncytial Virus Vaccinesuspension50024-311DRUG FOR FURTHER PROCESSING
-Respiratory Syncytial Virus Vaccinesuspension68263-003DRUG FOR FURTHER PROCESSING
-Sterile Water for Injectioninjection50024-001BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Sterile Water for Injectioninjection50024-002BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Sterile Water for Injectioninjection50024-004BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Sterile Water for Injectioninjection50024-005BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Sterile Water for Injectioninjection50024-006BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Sterile Water for injectioninjection50024-003BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING
-Taurolidine, Heparinsolution68263-223DRUG FOR FURTHER PROCESSING
-Taurolidine, Heparinsolution68263-224DRUG FOR FURTHER PROCESSING
-alendronate sodium and cholecalciferoltablet68263-387DRUG FOR FURTHER PROCESSING
-alendronate sodium and cholecalciferoltablet68263-674DRUG FOR FURTHER PROCESSING
Neighbours

Registered in the same town

5
Compare

Comparable companies in Spain

Enquiry

Common questions

Is ROVI Pharma Industrial Services S.A. FDA approved?
ROVI Pharma Industrial Services S.A. holds 4 FDA-registered establishments in Spain. Registration puts a site on the FDA's register and open to inspection; it is not an approval of the company. Approvals attach to individual drug applications.
Where are ROVI Pharma Industrial Services S.A.'s drugs manufactured?
The FDA register lists Alcala de Henares; Illescas; Madrid; San Sebasti�n de los Reyes. Registered operations: analytical testing, labelling, finished drug manufacture, packaging, sterilize.
What drugs does ROVI Pharma Industrial Services S.A. make?
16 products are listed under ROVI Pharma Industrial Services S.A. in the openFDA NDC Directory, most often as injection; injection, suspension; solution. The full breakdown by dosage form and route is above. A listing count is not a sales figure.

Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.